What actually decides an IP dispute — the strength of your rights, or the machinery around them? This past week delivered three very different answers to that question, and each one points to the same conclusion for business leaders: outcomes are built long before anyone reaches a courtroom. If you own patents, license technology, or build products on AI, the week’s developments are worth ten minutes of your attention — because the lessons are about IP strategy, not just law.

Enforcement leverage lives where your counterparty’s revenue lives

Ericsson and smartphone maker Transsion signed a global patent cross-licence this week, ending a dispute that stretched across four continents and nine jurisdictions — and nearly a decade of stalled negotiation before that. What changed? Days earlier, a court in Casablanca issued Africa’s first-ever standard essential patent injunctions, targeting a market where Transsion holds a commanding share.

The durable lesson is not about telecoms. It is that patent enforcement works when it is aimed at the counterparty’s actual revenue, not at the venues lawyers find most comfortable. A licensing negotiation is a pricing conversation, and price follows leverage. If you hold rights, map where your counterparty makes money and ask whether you can credibly act there. If you are the one paying royalties, the emerging-market safe harbours you have been relying on are closing. Either way, structure matters as much in settlement as in suit — a point explored in The Reverse Payment You Didn’t Know You Made, on how the economics buried inside a patent settlement can carry risks of their own.

In the AI and copyright fight, records are the battlefield

In the consolidated US litigation over AI training on news content, major publishers asked the court to sanction OpenAI, alleging the company withheld datasets and output logs central to the case. Whatever the court decides, notice what the fight is actually about: not fair use doctrine, but records — what data was used, where it came from, and who can prove it.

That is the evergreen point for any organisation building or deploying AI. Data provenance is no longer an engineering detail; it is litigation evidence, licensing currency and due-diligence material in every future transaction. If you cannot say what went into your models — or what your teams are feeding into someone else’s — you are carrying unquantified risk. The same discipline problem arises inside businesses adopting AI agents, as discussed in Your AI Agent Won’t Keep a Secret: when systems generate and move information without a human in the loop, information governance becomes IP strategy.

A patent asserted is a patent audited

At Europe’s Unified Patent Court, BioNTech and Pfizer saw off an infringement claim over their COVID-19 vaccine when the Munich division not only rejected infringement but revoked the asserted mRNA patent across Germany, France and Sweden in a single stroke.

Two lessons travel well beyond pharma. First, for patentees: asserting a right invites a validity audit, and in the UPC a loss is a loss everywhere at once. Before you enforce, pressure-test the asset as ruthlessly as your opponent will. Second, for operating companies: the same central mechanism that threatens pan-European injunctions can deliver pan-European freedom to operate — a revocation counterclaim is a strategic weapon, not just a defence. The UPC’s expanding reach, and what it means for your patent litigation map, is examined in One Court, Many Borders: Why the UPC Just Redrew Your Litigation Map.

The connecting thread

Strip out the industries and one pattern remains: in each development, the decisive asset was infrastructure — a venue strategy matched to the counterparty’s markets, a defensible data trail, a patent that could survive hostile scrutiny. Rights on paper did not decide anything this week. Preparation did.

Three things to check this quarter: Where would enforcement (by you or against you) actually bite commercially — and does your IP portfolio management reflect that map? Could you document, today, what data your AI tools have consumed? And if you asserted your most valuable patent tomorrow, would it survive the audit? If any answer is uncomfortable, that is the work — and it is far cheaper done now, with your patent attorney or IP strategist, than mid-dispute.